Risk Of Lobular Breast Cancer Increased Fourfold After Just 3 Years Of Combined HRT
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.”Previous research indicated that five or more years of combined hormone-therapy use was necessary to increase overall breast-cancer risk,” said Christopher I. Li, M.D., Ph.D.
More: continued here